“This SIGNIFICANT adverse event signal was NOT REPORTED by Pfizer”

The analysis reported here is unique

… is the first study of the original data from the Pfizer/BioNTech BNT162b2 mRNA vaccine clinical trial (CA4591001)

… carried out by a group unaffiliated with the trial sponsor

… 38 trial subjects who died between July 27, 2020, the start of Phase 2/3 of the clinical trial

… and March 13, 2021, the data end date of their 6-Month Interim Report

…At Week 20, when the BNT162b2 mRNA vaccine received Emergency Use Authorization from the U.S. FDA

… subjects in the placebo arm were given the option to be BNT162b2 vaccinated

… All but a few accepted

… Surprisingly … no significant difference between the number of deaths

in the vaccinated versus placebo arms

for the first 20 weeks of the trial, the placebo-controlled portion of the trial

… Our analysis revealed inconsistencies between the subject data listed in the 6-Month Interim Report and publications authored by Pfizer/BioNTech trial site administrators

… we found evidence of an over 3.7-fold increase in number of deaths due to cardiovascular events in BNT162b2 vaccinated subjects compared to Placebo controls

… This significant adverse event signal was not reported by Pfizer/BioNTech

             IJVTPR

                      Abstract